Vidupiprant

DB12272InvestigationalSmall molecule

Vidupiprant has been used in trials studying the treatment and basic science of Asthma.

Mechanism: Pharmacologically active on Prostaglandin D2 receptor and Prostaglandin D2 receptor 2
Curator reviewed
Formula / weight: C₂₈H₂₇Cl₂FN₂O₆S · 609.49 g/mol (avg)
Code names: AMG-853

Resolves to

Compound

Structure

InChIKeyPFWVGKROPKKEDW-UHFFFAOYSA-NSMILESCC(C)(C)NC(=O)C1=CC=C(OC2=CC(F)=C(CC(O)=O)C=C2Cl)C(NS(=O)(=O)C2=CC=C(C=C2Cl)C2CC2)=C1

Targets

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Vidupiprant, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.